Market Intelligence chevron_right Medical Care chevron_right LFA-based Cardiac Marker
Global Report 2022

Global LFA-based Cardiac Marker Market Insights and Forecast to 2031

calendar_todayPublished: Apr 2022 descriptionPages: 107 categoryCategory: Medical Care
cloud_downloadRequest Sample Report
mailPre-Order Enquiry
local_offerGet Discount 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Troponin
        1.2.3 CK-MB
        1.2.4 Myoglobin
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Laboratory Testing
        1.3.3 Point-of-care Testing
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global LFA-based Cardiac Marker Market Perspective (2017-2028)
    2.2 LFA-based Cardiac Marker Growth Trends by Region
        2.2.1 LFA-based Cardiac Marker Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 LFA-based Cardiac Marker Historic Market Size by Region (2017-2022)
        2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Region (2023-2028)
    2.3 LFA-based Cardiac Marker Market Dynamics
        2.3.1 LFA-based Cardiac Marker Industry Trends
        2.3.2 LFA-based Cardiac Marker Market Drivers
        2.3.3 LFA-based Cardiac Marker Market Challenges
        2.3.4 LFA-based Cardiac Marker Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top LFA-based Cardiac Marker Players by Revenue
        3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2017-2022)
        3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2017-2022)
    3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
    3.4 Global LFA-based Cardiac Marker Market Concentration Ratio
        3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2021
    3.5 LFA-based Cardiac Marker Key Players Head office and Area Served
    3.6 Key Players LFA-based Cardiac Marker Product Solution and Service
    3.7 Date of Enter into LFA-based Cardiac Marker Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 LFA-based Cardiac Marker Breakdown Data by Type
    4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2017-2022)
    4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2023-2028)
5 LFA-based Cardiac Marker Breakdown Data by Application
    5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2017-2022)
    5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America LFA-based Cardiac Marker Market Size (2017-2028)
    6.2 North America LFA-based Cardiac Marker Market Size by Type
        6.2.1 North America LFA-based Cardiac Marker Market Size by Type (2017-2022)
        6.2.2 North America LFA-based Cardiac Marker Market Size by Type (2023-2028)
        6.2.3 North America LFA-based Cardiac Marker Market Share by Type (2017-2028)
    6.3 North America LFA-based Cardiac Marker Market Size by Application
        6.3.1 North America LFA-based Cardiac Marker Market Size by Application (2017-2022)
        6.3.2 North America LFA-based Cardiac Marker Market Size by Application (2023-2028)
        6.3.3 North America LFA-based Cardiac Marker Market Share by Application (2017-2028)
    6.4 North America LFA-based Cardiac Marker Market Size by Country
        6.4.1 North America LFA-based Cardiac Marker Market Size by Country (2017-2022)
        6.4.2 North America LFA-based Cardiac Marker Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe LFA-based Cardiac Marker Market Size (2017-2028)
    7.2 Europe LFA-based Cardiac Marker Market Size by Type
        7.2.1 Europe LFA-based Cardiac Marker Market Size by Type (2017-2022)
        7.2.2 Europe LFA-based Cardiac Marker Market Size by Type (2023-2028)
        7.2.3 Europe LFA-based Cardiac Marker Market Share by Type (2017-2028)
    7.3 Europe LFA-based Cardiac Marker Market Size by Application
        7.3.1 Europe LFA-based Cardiac Marker Market Size by Application (2017-2022)
        7.3.2 Europe LFA-based Cardiac Marker Market Size by Application (2023-2028)
        7.3.3 Europe LFA-based Cardiac Marker Market Share by Application (2017-2028)
    7.4 Europe LFA-based Cardiac Marker Market Size by Country
        7.4.1 Europe LFA-based Cardiac Marker Market Size by Country (2017-2022)
        7.4.2 Europe LFA-based Cardiac Marker Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2017-2028)
    8.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type
        8.2.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific LFA-based Cardiac Marker Market Share by Type (2017-2028)
    8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Application
        8.3.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific LFA-based Cardiac Marker Market Share by Application (2017-2028)
    8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region
        8.4.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America LFA-based Cardiac Marker Market Size (2017-2028)
    9.2 Latin America LFA-based Cardiac Marker Market Size by Type
        9.2.1 Latin America LFA-based Cardiac Marker Market Size by Type (2017-2022)
        9.2.2 Latin America LFA-based Cardiac Marker Market Size by Type (2023-2028)
        9.2.3 Latin America LFA-based Cardiac Marker Market Share by Type (2017-2028)
    9.3 Latin America LFA-based Cardiac Marker Market Size by Application
        9.3.1 Latin America LFA-based Cardiac Marker Market Size by Application (2017-2022)
        9.3.2 Latin America LFA-based Cardiac Marker Market Size by Application (2023-2028)
        9.3.3 Latin America LFA-based Cardiac Marker Market Share by Application (2017-2028)
    9.4 Latin America LFA-based Cardiac Marker Market Size by Country
        9.4.1 Latin America LFA-based Cardiac Marker Market Size by Country (2017-2022)
        9.4.2 Latin America LFA-based Cardiac Marker Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2017-2028)
    10.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type
        10.2.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa LFA-based Cardiac Marker Market Share by Type (2017-2028)
    10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Application
        10.3.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa LFA-based Cardiac Marker Market Share by Application (2017-2028)
    10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country
        10.4.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Thermo Fisher
        11.1.1 Thermo Fisher Company Details
        11.1.2 Thermo Fisher Business Overview
        11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction
        11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.1.5 Thermo Fisher Recent Developments
    11.2 Bio-Rad Laboratories
        11.2.1 Bio-Rad Laboratories Company Details
        11.2.2 Bio-Rad Laboratories Business Overview
        11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
        11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.2.5 Bio-Rad Laboratories Recent Developments
    11.3 Becton, Dickinson
        11.3.1 Becton, Dickinson Company Details
        11.3.2 Becton, Dickinson Business Overview
        11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction
        11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.3.5 Becton, Dickinson Recent Developments
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche LFA-based Cardiac Marker Introduction
        11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.4.5 Roche Recent Developments
    11.5 Hologic
        11.5.1 Hologic Company Details
        11.5.2 Hologic Business Overview
        11.5.3 Hologic LFA-based Cardiac Marker Introduction
        11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.5.5 Hologic Recent Developments
    11.6 Abbott
        11.6.1 Abbott Company Details
        11.6.2 Abbott Business Overview
        11.6.3 Abbott LFA-based Cardiac Marker Introduction
        11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.6.5 Abbott Recent Developments
    11.7 Siemens
        11.7.1 Siemens Company Details
        11.7.2 Siemens Business Overview
        11.7.3 Siemens LFA-based Cardiac Marker Introduction
        11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.7.5 Siemens Recent Developments
    11.8 Danaher
        11.8.1 Danaher Company Details
        11.8.2 Danaher Business Overview
        11.8.3 Danaher LFA-based Cardiac Marker Introduction
        11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.8.5 Danaher Recent Developments
    11.9 Alere
        11.9.1 Alere Company Details
        11.9.2 Alere Business Overview
        11.9.3 Alere LFA-based Cardiac Marker Introduction
        11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.9.5 Alere Recent Developments
    11.10 BioMérieux
        11.10.1 BioMérieux Company Details
        11.10.2 BioMérieux Business Overview
        11.10.3 BioMérieux LFA-based Cardiac Marker Introduction
        11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.10.5 BioMérieux Recent Developments
    11.11 LSI
        11.11.1 LSI Company Details
        11.11.2 LSI Business Overview
        11.11.3 LSI LFA-based Cardiac Marker Introduction
        11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.11.5 LSI Recent Developments
    11.12 Clinical Diagnostics
        11.12.1 Clinical Diagnostics Company Details
        11.12.2 Clinical Diagnostics Business Overview
        11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction
        11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.12.5 Clinical Diagnostics Recent Developments
    11.13 Randox laboratories
        11.13.1 Randox laboratories Company Details
        11.13.2 Randox laboratories Business Overview
        11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction
        11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.13.5 Randox laboratories Recent Developments
    11.14 Wondfo Biotech
        11.14.1 Wondfo Biotech Company Details
        11.14.2 Wondfo Biotech Business Overview
        11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
        11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2017-2022)
        11.14.5 Wondfo Biotech Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Troponin
    Table 3. Key Players of CK-MB
    Table 4. Key Players of Myoglobin
    Table 5. Key Players of Others
    Table 6. Global LFA-based Cardiac Marker Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global LFA-based Cardiac Marker Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global LFA-based Cardiac Marker Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global LFA-based Cardiac Marker Market Share by Region (2017-2022)
    Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global LFA-based Cardiac Marker Market Share by Region (2023-2028)
    Table 12. LFA-based Cardiac Marker Market Trends
    Table 13. LFA-based Cardiac Marker Market Drivers
    Table 14. LFA-based Cardiac Marker Market Challenges
    Table 15. LFA-based Cardiac Marker Market Restraints
    Table 16. Global LFA-based Cardiac Marker Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global LFA-based Cardiac Marker Revenue Share by Players (2017-2022)
    Table 18. Global Top LFA-based Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2021)
    Table 19. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players LFA-based Cardiac Marker Product Solution and Service
    Table 23. Date of Enter into LFA-based Cardiac Marker Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2017-2022)
    Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2023-2028)
    Table 29. Global LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global LFA-based Cardiac Marker Revenue Share by Application (2017-2022)
    Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global LFA-based Cardiac Marker Revenue Share by Application (2023-2028)
    Table 33. North America LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America LFA-based Cardiac Marker Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America LFA-based Cardiac Marker Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America LFA-based Cardiac Marker Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America LFA-based Cardiac Marker Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe LFA-based Cardiac Marker Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe LFA-based Cardiac Marker Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe LFA-based Cardiac Marker Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe LFA-based Cardiac Marker Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific LFA-based Cardiac Marker Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific LFA-based Cardiac Marker Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific LFA-based Cardiac Marker Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific LFA-based Cardiac Marker Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America LFA-based Cardiac Marker Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America LFA-based Cardiac Marker Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America LFA-based Cardiac Marker Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America LFA-based Cardiac Marker Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa LFA-based Cardiac Marker Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa LFA-based Cardiac Marker Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa LFA-based Cardiac Marker Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa LFA-based Cardiac Marker Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa LFA-based Cardiac Marker Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa LFA-based Cardiac Marker Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Thermo Fisher Company Details
    Table 64. Thermo Fisher Business Overview
    Table 65. Thermo Fisher LFA-based Cardiac Marker Product
    Table 66. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 67. Thermo Fisher Recent Developments
    Table 68. Bio-Rad Laboratories Company Details
    Table 69. Bio-Rad Laboratories Business Overview
    Table 70. Bio-Rad Laboratories LFA-based Cardiac Marker Product
    Table 71. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 72. Bio-Rad Laboratories Recent Developments
    Table 73. Becton, Dickinson Company Details
    Table 74. Becton, Dickinson Business Overview
    Table 75. Becton, Dickinson LFA-based Cardiac Marker Product
    Table 76. Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 77. Becton, Dickinson Recent Developments
    Table 78. Roche Company Details
    Table 79. Roche Business Overview
    Table 80. Roche LFA-based Cardiac Marker Product
    Table 81. Roche Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 82. Roche Recent Developments
    Table 83. Hologic Company Details
    Table 84. Hologic Business Overview
    Table 85. Hologic LFA-based Cardiac Marker Product
    Table 86. Hologic Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 87. Hologic Recent Developments
    Table 88. Abbott Company Details
    Table 89. Abbott Business Overview
    Table 90. Abbott LFA-based Cardiac Marker Product
    Table 91. Abbott Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 92. Abbott Recent Developments
    Table 93. Siemens Company Details
    Table 94. Siemens Business Overview
    Table 95. Siemens LFA-based Cardiac Marker Product
    Table 96. Siemens Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 97. Siemens Recent Developments
    Table 98. Danaher Company Details
    Table 99. Danaher Business Overview
    Table 100. Danaher LFA-based Cardiac Marker Product
    Table 101. Danaher Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 102. Danaher Recent Developments
    Table 103. Alere Company Details
    Table 104. Alere Business Overview
    Table 105. Alere LFA-based Cardiac Marker Product
    Table 106. Alere Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 107. Alere Recent Developments
    Table 108. BioMérieux Company Details
    Table 109. BioMérieux Business Overview
    Table 110. BioMérieux LFA-based Cardiac Marker Product
    Table 111. BioMérieux Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 112. BioMérieux Recent Developments
    Table 113. LSI Company Details
    Table 114. LSI Business Overview
    Table 115. LSI LFA-based Cardiac Marker Product
    Table 116. LSI Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 117. LSI Recent Developments
    Table 118. Clinical Diagnostics Company Details
    Table 119. Clinical Diagnostics Business Overview
    Table 120. Clinical Diagnostics LFA-based Cardiac Marker Product
    Table 121. Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 122. Clinical Diagnostics Recent Developments
    Table 123. Randox laboratories Company Details
    Table 124. Randox laboratories Business Overview
    Table 125. Randox laboratories LFA-based Cardiac Marker Product
    Table 126. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 127. Randox laboratories Recent Developments
    Table 128. Wondfo Biotech Company Details
    Table 129. Wondfo Biotech Business Overview
    Table 130. Wondfo Biotech LFA-based Cardiac Marker Product
    Table 131. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2017-2022) & (US$ Million)
    Table 132. Wondfo Biotech Recent Developments
    Table 133. Research Programs/Design for This Report
    Table 134. Key Data Information from Secondary Sources
    Table 135. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global LFA-based Cardiac Marker Market Share by Type: 2021 VS 2028
    Figure 2. Troponin Features
    Figure 3. CK-MB Features
    Figure 4. Myoglobin Features
    Figure 5. Others Features
    Figure 6. Global LFA-based Cardiac Marker Market Share by Application: 2021 VS 2028
    Figure 7. Laboratory Testing Case Studies
    Figure 8. Point-of-care Testing Case Studies
    Figure 9. LFA-based Cardiac Marker Report Years Considered
    Figure 10. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global LFA-based Cardiac Marker Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global LFA-based Cardiac Marker Market Share by Region: 2021 VS 2028
    Figure 13. Global LFA-based Cardiac Marker Market Share by Players in 2021
    Figure 14. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2021
    Figure 16. North America LFA-based Cardiac Marker Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America LFA-based Cardiac Marker Market Size Market Share by Type (2017-2028)
    Figure 18. North America LFA-based Cardiac Marker Market Size Market Share by Application (2017-2028)
    Figure 19. North America LFA-based Cardiac Marker Market Size Share by Country (2017-2028)
    Figure 20. United States LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe LFA-based Cardiac Marker Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe LFA-based Cardiac Marker Market Size Market Share by Type (2017-2028)
    Figure 24. Europe LFA-based Cardiac Marker Market Size Market Share by Application (2017-2028)
    Figure 25. Europe LFA-based Cardiac Marker Market Size Share by Country (2017-2028)
    Figure 26. Germany LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific LFA-based Cardiac Marker Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific LFA-based Cardiac Marker Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific LFA-based Cardiac Marker Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific LFA-based Cardiac Marker Market Size Share by Region (2017-2028)
    Figure 36. China LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America LFA-based Cardiac Marker Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America LFA-based Cardiac Marker Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America LFA-based Cardiac Marker Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America LFA-based Cardiac Marker Market Size Share by Country (2017-2028)
    Figure 46. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa LFA-based Cardiac Marker Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa LFA-based Cardiac Marker Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa LFA-based Cardiac Marker Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa LFA-based Cardiac Marker Market Size Share by Country (2017-2028)
    Figure 52. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE LFA-based Cardiac Marker Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 56. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 57. Becton, Dickinson Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 58. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 59. Hologic Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 60. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 61. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 62. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 63. Alere Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 64. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 65. LSI Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 66. Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 67. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 68. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2017-2022)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Thermo Fisher
Bio-Rad Laboratories
Becton, Dickinson
Roche
Hologic
Abbott
Siemens
Danaher
Alere
BioMérieux
LSI
Clinical Diagnostics
Randox laboratories
Wondfo Biotech

Frequently Asked Questions

What is the USP of the report? expand_more
LFA-based Cardiac Marker report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
What are the key content of the report? expand_more
LFA-based Cardiac Marker report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
What are the value propositions and opportunities offered in this market research report? expand_more
LFA-based Cardiac Marker report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.